A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
Clinical trial NCT06880744 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06880744
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-17
- Primary completion
- 2027-08-01
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.